Table 1 Demographic and medical characteristics
Variable | Gout | Asymptomatic hyperuricaemia | Control | |
|---|---|---|---|---|
N | 24 | 29 | 34 | |
Gender, male, n (%) | 24 (100 %) | 29 (100 %) | 34 (100 %) | |
Age, years, mean (SD) | 58 (13) | 58 (19) | 58 (14) | |
Ethnicity, n (%) | European 14 (58 %) | European 24 (83 %) | European 30 (88 %) | |
Maori 1 (4 %) | Maori 0 (0 %) | Maori 1 (3 %) | ||
Pacific 5 (21 %) | Pacific 3 (10 %) | Pacific 0 (0 %) | ||
Asian 4 (17 %) | Asian 2 (7 %) | Asian 3 (9 %) | ||
BMI, kg/m2, mean (SD) | 30.2 (4.0)* | 29.3 (5.9)* | 25.0 (2.9) | |
Diuretic use, n (%) | 3 (12 %) | 7 (24 %) | 4 (12 %) | |
NSAID use, n (%) | 14 (58 %)* | 11 (38 %) | 7 (21 %) | |
Prednisone use, n (%) | 5 (21 %) | 0 (0 %) | 0 (0 %) | |
Hypertension, n (%) | 17 (70 %)* | 16 (55 %)* | 9 (26 %) | |
Cardiovascular disease, n (%) | 7 (29 %)* | 5 (17 %) | 1 (3 %) | |
Diabetes, n (%) | 4 (17 %) | 1 (3 %) | 2 (6 %) | |
Urate, mmol/l | Mean (SD) | 0.35 (0.10) | 0.46 (0.05)* | 0.32 (0.06) |
Range | 0.24 - 0.63 | 0.41 - 0.63 | 0.20 - 0.40 | |
1MTPJ tenderness, n (%) | Right | 4 (17 %) | 1 (0 %) | 0 (0 %) |
Left | 3 (12 %) | 0 (0 %) | 1 (3 %) | |
1MTPJ swelling, n (%) | Right | 1 (4 %) | 0 (0 %) | 0 (0 %) |
Left | 0 (0 %) | 0 (0 %) | 0 (0 %) | |
66/68 joint count, mean (SD) | Tender | 2.7 (6.1)* | 1.5 (1.9) | 0.6 (1.2) |
Swollen | 1.0 (1.7)* | 0.2 (0.7) | 0.0 (0.0) | |